Bungwe la World Health Organization (WHO) lalengeza lero kuti GlaxoSmithKline (GSK) ikonzanso kudzipereka kwake kupereka mankhwala ophera tizilombo toyambitsa matenda albendazole mpaka kuthetsa kuchotsedwa kwa lymphatic filariasis monga vuto la thanzi la anthu. Kuphatikiza apo, pofika 2025, mapiritsi 200 miliyoni pachaka ochizira matenda a STH adzaperekedwa, ndipo pofika 2025, mapiritsi 5 miliyoni pachaka ochizira cystic echinococcosis.
Chilengezo chaposachedwachi chikugwirizana ndi kudzipereka kwa kampani kwa zaka 23 polimbana ndi matenda atatu a Neglected Tropical Diseases (NTDs) omwe akuwononga kwambiri madera ena osauka kwambiri padziko lapansi.
Malonjezanowa ndi mbali chabe ya kudzipereka kochititsa chidwi komwe GSK anachita lero pa Msonkhano wa Matenda a Malungo ndi Osasamala ku Kigali, komwe adalengeza ndalama zokwana £ 1 biliyoni pazaka 10 kuti apititse patsogolo chitukuko cha matenda opatsirana. - mayiko opeza ndalama. Cholengeza munkhani).
Kafukufukuyu adzayang'ana pa mankhwala opambana atsopano ndi katemera kuti ateteze ndi kuchiza malungo, chifuwa chachikulu, kachilombo ka HIV (kudzera mu ViiV Healthcare) ndi matenda osasamalidwa a m'madera otentha, ndi kuthana ndi kukana kwa antimicrobial, komwe kukupitirizabe kukhudza anthu omwe ali pachiopsezo chachikulu komanso kupha anthu ambiri. . Mtolo wa matenda m'mayiko ambiri otsika kwambiri umaposa 60%.